Erratum: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts (Oncotarget (2019) 10 (6269-6282) DOI: 10.18632/oncotarget.27268)

Leonid Visochek, Dikla Atias, Itay Spektor, Asher Castiel, Talia Golan, Malka Cohen-Armon

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: Due to an error during image processing, frame 6 of tumor #1 (one of the control tumors) in Figure 4D is an accidental duplicate of frame 5. At Oncotarget's request, the authors provided the original data. An original, correct Figure 4D is presented here. The authors declare that these corrections do not change the results or conclusions of this paper. (Figure Presented).

Original languageEnglish
Pages (from-to)571-575
Number of pages5
JournalOncotarget
Volume11
Issue number5
DOIs
StatePublished - 1 Feb 2020

Fingerprint

Dive into the research topics of 'Erratum: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts (Oncotarget (2019) 10 (6269-6282) DOI: 10.18632/oncotarget.27268)'. Together they form a unique fingerprint.

Cite this